VIA
VOR icon

Virtus Investment Advisers’s Vor Biopharma VOR Stock Holding History

Virtus Investment Advisers’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Buy
+22,785
New +$345K 0.1% 252

Other funds holding VOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Virtus Investment Advisers's VOR Position: Q2 2026 in Review

Virtus Investment Advisers opened a new position in Vor Biopharma (VOR) in Q2 2026: 22,785 shares worth $419K. The stake represents 0.1% of the portfolio and ranks #252 among its holdings.

31 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Virtus Investment Advisers held 22,785 shares of Vor Biopharma worth $419K as of Q2 2026.
  • Vor Biopharma was a new Virtus Investment Advisers position in Q2 2026.
  • Vor Biopharma made up 0.1% of Virtus Investment Advisers's portfolio in Q2 2026, its #252 holding.
  • 31 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.